Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 23, 2026 08:00 ET | Source: BrainsWay

BrainsWay to Participate in the Citi 2026 Unplugged MedTech and Life Sciences Access Day

BURLINGTON, Mass. and JERUSALEM, Feb. 23, 2026 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive brain stimulation...
February 20, 2026 16:05 ET | Source: Foresight Autonomous Holdings Ltd.

Foresight Announced ADS Ratio Change

Ness Ziona, Israel, Feb. 20, 2026 (GLOBE NEWSWIRE) -- Foresight Autonomous Holdings Ltd. (Nasdaq and TASE: FRSX) (“Foresight” or the “Company”), an innovator in automotive vision systems, today...
February 20, 2026 14:43 ET | Source: Teva Pharmaceutical Industries Ltd

U.S. Food and Drug Administration (FDA) Accepts Teva’s New Drug Application (NDA) for Olanzapine Extended-Release Injectable Suspension (TEV-'749) for the Once-Monthly Treatment of Schizophrenia in Adults

Olanzapine long-acting injectable (LAI) suspension (TEV-'749) has the potential to offer the efficacy of olanzapine in a once-monthly, subcutaneous formulation1If approved, TEV-'749 could help address...
February 19, 2026 07:30 ET | Source: BrainsWay

BrainsWay Announces New Minority-Stake Investment in Canadian Provider, BrainStim Health Inc.

BrainsWay continues to actively evaluate similar investments in leading North American mental health providers to raise awareness and expand access to transformative care BURLINGTON, Mass. and...
February 19, 2026 06:00 ET | Source: Tower Semiconductor

Xanadu and Tower Semiconductor Deepen Strategic Collaboration to Accelerate Photonic Quantum Hardware Innovation

Strengthening the manufacturing foundation for commercial-scale photonic quantum computing MIGDAL HAEMEK, Israel, and Toronto, ON, February 19, 2026 - Tower Semiconductor, the leading foundry of...
February 18, 2026 08:00 ET | Source: Pluri Inc.

Pluri Secures Global IP Position with China Patent Grant for Large-Scale Immune Cell Expansion, Complementing Prior U.S. Patent

Expands patent protection across major global pharmaceutical markets, including the U.S., China and Asia-Pacific Enables scalable, automated manufacturing of diverse immune cell therapies using...
February 18, 2026 07:30 ET | Source: Nayax Ltd.

Nayax Announces Global Partnership with DC Fast Charger OEM Tritium to Simplify EV Charger Payment Enablement

HERZLIYA, Israel, Feb. 18, 2026 (GLOBE NEWSWIRE) -- Nayax Ltd. (Nasdaq: NYAX; TASE: NYAX), a global commerce enablement, payments, and loyalty platform designed to help merchants scale their...
February 18, 2026 07:30 ET | Source: BrainsWay

BrainsWay Reports Cigna’s Evernorth Behavioral Health to Eliminate Prior Authorization Requirements for TMS Coverage, Accelerating Access to Care

BURLINGTON, Mass. and JERUSALEM, Feb. 18, 2026 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive brain stimulation...
February 17, 2026 09:00 ET | Source: Nayax Ltd.

Nayax to Report Q4 and FY 2025 Earnings on March 9, 2026

HERZLIYA, Israe, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Nayax Ltd. (Nasdaq: NYAX; TASE: NYAX), a global commerce enablement and payments platform designed to help merchants scale their business by...
February 17, 2026 07:30 ET | Source: BrainsWay

BrainsWay Announces Change in ADS-to-Ordinary Share Ratio

BURLINGTON, Mass. and JERUSALEM, Feb. 17, 2026 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive brain stimulation...